The DOI matches its Crossref record.
Prefrontal cortical hypometabolism during low-dose interferon alpha treatment
Abstract
Objective To evaluate prospectively interferon alpha (IFN-alpha) associated effects on cerebral glucose metabolism and its correlation to neuropsychiatric symptoms during low-dose IFN-alpha-treatment. Methods Eleven patients treated with low-dose IFN-alpha for chronic hepatitis C were prospectively evaluated by neuropsychiatric tests and cerebral [18F]deoxyglucose positron emission tomography (FDG-PET) before and in the 12th week of treatment. PET images were spatially normalized, corrected for variance in global activity and pixel-based t-statistics were calculated for each set of PET scans using SPM96 software. Pixel-cluster with P Results In week 12 of IFN-alpha treatment, significant hypometabolism with a decrease of local activity ranging from 8 to 12% was found in all patients bilaterally in the prefrontal cortex (BA 9), which correlated in a covariate analysis with changes in depression score as measured by Beck's Depression Inventory. Additionally, hypermetabolism with a maximum increase in local activity of 6-8% was seen in all patients in putamina as well as the left occipital region (BA 18). Before IFN-alpha treatment, only 1/11 patient showed depressive symptomatology. After 3 months of treatment, 6/11 patients were classified as having mild to moderate depressive symptoms (P Conclusions Low-dose IFN-alpha therapy is associated with significant prefrontal hypometabolism. This hypometabolism covaried with depression score, but was even found in clinically non-depre…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Positron emission tomography (PET) studies have revealed that the application of IFN-α leads to increases in basal ganglia glucose metabolism (109, 110).”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [109]
Citations
Cites
Still being checked.
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
Miller, A. H., Haroon, E., Raison, C. L., & Felger, J. C. (2013) · Depression and Anxiety · doi:10.1002/da.22084 · Cited by 892
Cytokine, Sickness Behavior, and Depression
Dantzer, R. (2009) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2009.02.002 · Cited by 789
Inflammation-associated depression: From serotonin to kynurenine
Dantzer, R., O’Connor, J. C., Lawson, M. A., & Kelley, K. W. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.09.012 · Cited by 726
Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
Miller, A. H., Ancoli-Israel, S., Bower, J. E., Capuron, L., & Irwin, M. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.7805 · Cited by 608
Cytokines and psychopathology: Lessons from interferon-α
Capuron, L., & Miller, A. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.009 · Cited by 562
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 442
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Felger, J. C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171123201142 · Cited by 427
Neuromodulation by the immune system: a focus on cytokines
Salvador, A. F., de Lima, K. A., & Kipnis, J. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00508-z · Cited by 389
Felger, J. C., & Miller, A. H. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.09.003 · Cited by 391
Capuron, L., Pagnoni, G., Drake, D. F., Woolwine, B. J., Spivey, J. R., Crowe, R. J., Votaw, J. R., Goodman, M. M., & Miller, A. H. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2094 · Cited by 382
Bower, J. E., & Lamkin, D. M. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.011 · Cited by 372
Inflammation, Depression and Dementia: Are they Connected?
Leonard, B. E. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9385-y · Cited by 342
Cytokine, sickness behavior, and depression
Dantzer, R. (2006) · Neurologic Clinics · doi:10.1016/j.ncl.2006.03.003 · Cited by 340
Depression and immunity: A role for T cells?
Miller, A. H. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.09.009 · Cited by 337
Depression in cancer: new developments regarding diagnosis and treatment
Raison, C. L., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00413-x · Cited by 336
ANISMAN, H., MERALI, Z., & HAYLEY, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 337
The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans
Wichers, M., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003103 · Cited by 329
Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer
Bower, J. E., Ganz, P. A., Tao, M. L., Hu, W., Belin, T. R., Sepah, S., Cole, S., & Aziz, N. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2584 · Cited by 315
Cytokine Research in Depression: Principles, Challenges, and Open Questions
Himmerich, H., Patsalos, O., Lichtblau, N., Ibrahim, M. A. A., & Dalton, B. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00030 · Cited by 313
Inflammation, Glutamate, and Glia in Depression:A Literature Review
McNally, L., Bhagwagar, Z., & Hannestad, J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016734 · Cited by 289
Wichers, M. C., & Maes, M. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0402 · Cited by 285
Miller, A. H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.006 · Cited by 261
Shelton, R. C., & Miller, A. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.004 · Cited by 261
Side effects of therapy for chronic hepatitis C
Russo, M. W., & Fried, M. W. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00394-9 · Cited by 261
Basal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy
Capuron, L., Pagnoni, G., Demetrashvili, M. F., Lawson, D. H., Fornwalt, F. B., Woolwine, B., Berns, G. S., Nemeroff, C. B., & Miller, A. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301362 · Cited by 229
The phenomenology and treatment of interferon-induced depression
Loftis, J. M., & Hauser, P. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.04.002 · Cited by 226
Inflammation-Related Functional and Structural Dysconnectivity as a Pathway to Psychopathology
Goldsmith, D. R., Bekhbat, M., Mehta, N. D., & Felger, J. C. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.11.003 · Cited by 214
Interferon alpha (IFNα) and psychiatric syndromes
Schaefer, M., Engelbrechta, M. A., Gut, O., Fiebich, B. L., Bauer, J., Schmidt, F., Grunze, H., & Lieb, K. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00324-4 · Cited by 202
Self-citationKim, K.-N., Lim, Y.-H., Bae, H. J., Kim, M., Jung, K., & Hong, Y.-C. (2016) · Environmental Health Perspectives · doi:10.1289/ehp192 · Cited by 200
Inflammatory cytokine-associated depression
Lotrich, F. E. (2015) · Brain Research · doi:10.1016/j.brainres.2014.06.032 · Cited by 183
The biology of depression in cancer and the relationship between depression and cancer progression
Sotelo, J. L., Musselman, D., & Nemeroff, C. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.875891 · Cited by 179
Wefel, J. S., Kayl, A. E., & Meyers, C. A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601772 · Cited by 167
Kraynak, T. E., Marsland, A. L., Wager, T. D., & Gianaros, P. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.013 · Cited by 165
“Seven studies examined clinical samples; these included participants with hepatitis C infection (Capuron et al., 2005; Juengling et al., 2000), melanoma (Capuron et al.”
BackgroundCapuron, L., Fornwalt, F. B., Knight, B. T., Harvey, P. D., Ninan, P. T., & Miller, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.02.017 · Cited by 164
Morris, G., Berk, M., Galecki, P., Walder, K., & Maes, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9090-9 · Cited by 161
Major Depression: One Brain, One Disease, One Set of Intertwined Processes
Filatova, E. V., Shadrina, M. I., & Slominsky, P. A. (2021) · Cells · doi:10.3390/cells10061283 · Cited by 160
Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
Miller, A. H., Haroon, E., & Felger, J. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.167 · Cited by 152
Herbert, J., & Lucassen, P. J. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.12.001 · Cited by 150
Cognitive Dysfunction in Chronic Hepatitis C: A Review
Perry, W., Hilsabeck, R. C., & Hassanein, T. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9896-z · Cited by 154
Inflammation in depression: is adiposity a cause?
Shelton, R. C., & Miller, A. H. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/rshelton · Cited by 161
Goldsmith, D. R., Haroon, E., Woolwine, B. J., Jung, M. Y., Wommack, E. C., Harvey, P. D., Treadway, M. T., Felger, J. C., & Miller, A. H. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.03.025 · Cited by 157
Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation
Grover, V. P. B., Pavese, N., Koh, S., Wylezinska, M., Saxby, B. K., Gerhard, A., Forton, D. M., Brooks, D. J., Thomas, H. C., & Taylor-Robinson, S. D. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01510.x · Cited by 139
Lotrich, F. E., Ferrell, R. E., Rabinovitz, M., & Pollock, B. G. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.009 · Cited by 146
Can’t or Won’t? Immunometabolic Constraints on Dopaminergic Drive
Treadway, M. T., Cooper, J. A., & Miller, A. H. (2019) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2019.03.003 · Cited by 153
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
Lucido, M. J., Bekhbat, M., Goldsmith, D. R., Treadway, M. T., Haroon, E., Felger, J. C., & Miller, A. H. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000043 · Cited by 137
Majer, M., Welberg, L. A. M., Capuron, L., Pagnoni, G., Raison, C. L., & Miller, A. H. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.009 · Cited by 124
Hoyo-Becerra, C., Schlaak, J., & Hermann, D. M. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.06.200 · Cited by 129
The role of dopamine in inflammation-associated depression: mechanisms and therapeutic implications
Felger, J. C. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_13 · Cited by 115
Inflammation, Self-Regulation, and Health: An Immunologic Model of Self-Regulatory Failure
Shields, G. S., Moons, W. G., & Slavich, G. M. (2017) · Perspectives on Psychological Science · doi:10.1177/1745691616689091 · Cited by 125
Depression following pegylated interferon-alpha: Characteristics and vulnerability
Lotrich, F. E., Rabinovitz, M., Gironda, P., & Pollock, B. G. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.05.013 · Cited by 100
Hepatitis C virus infection and the brain
Weißenborn, K., Tryc, A. B., Heeren, M., Worthmann, H., Pflugrad, H., Berding, G., Bokemeyer, M., Tillmann, H. L., & Goldbecker, A. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9130-5 · Cited by 105
Systemic interferon-α regulates interferon-stimulated genes in the central nervous system
Wang, J., Campbell, I. L., & Zhang, H. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002013 · Cited by 108
Cognitive Dysfunction and Depression During Treatment With Interferon-Alpha and Chemotherapy
Scheibel, R. S., Valentine, A. D., O'Brien, S. M., & Meyers, C. A. (2004) · Journal of Neuropsychiatry · doi:10.1176/jnp.16.2.185 · Cited by 99
Review: the role of inflammation in depression.
Patel, A. J. (2013) · PubMed · Cited by 119
Role of Inflammation in Depression and Treatment Implications
Felger, J. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_166 · Cited by 103
Hostinar, C. E., Nusslock, R., & Miller, G. E. (2018) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2016.1266647 · Cited by 90
“Cytokines may also dampen executive control-related processes linked to regions of the prefrontal cortex involved in executive control, decision making, and regulating threat-and reward-related tendencies (Harrison et al., 2009; Juengling et al., 2000).”
Role of Inflammation in Depression: Implications for Phenomenology, Pathophysiology and Treatment
Raison, C. L., & Miller, A. H. (2013) · Modern Trends in Psychiatry · doi:10.1159/000343966 · Cited by 88
Lieb, K., Engelbrecht, M. A., Gut, O., Fiebich, B. L., Bauer, J., Janssen, G., & Schaefer, M. (2006) · European Psychiatry · doi:10.1016/j.eurpsy.2004.09.030 · Cited by 77
Self-citationCasaril, A. M., Domingues, M., Fronza, M. G., Vieira, B. M., Begnini, K. R., Lenardao, E. J., Seixas, F. K., Collares, T. V., Nogueira, C. W., & Savegnago, L. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711713 · Cited by 77
Multiple sclerosis and depression: influence of interferon b therapy
Zéphir, H., Seze, J. D., Stojkovic, T., Delisse, B., Ferriby, D., Cabaret, M., & Vermersch, P. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms915oa · Cited by 75
Fritz, M., Klawonn, A. M., Nilsson, A., Singh, A. K., Zajdel, J., Wilhelms, D., Lazarus, M., Löfberg, A., Jaarola, M., Kugelberg, U. Ö., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83844 · Cited by 74
Major depression during interferon-α treatment: vulnerability and prevention
Lotrich, F. E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.4/felotrich · Cited by 77
Neurological and psychiatric effects of hepatitis C virus infection
Faccioli, J., Nardelli, S., Gioia, S., Riggio, O., & Ridola, L. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i29.4846 · Cited by 79
Inflammation as a Pathophysiologic Pathway to Anhedonia: Mechanisms and Therapeutic Implications
Bekhbat, M., Treadway, M. T., & Felger, J. C. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_294 · Cited by 73
Mackay, M. C. (2015) · Immunologic Research · doi:10.1007/s12026-015-8716-3 · Cited by 76
Crone, C. C., & Gabriel, G. M. (2003) · Journal of Psychiatric Practice · doi:10.1097/00131746-200303000-00002 · Cited by 66
Garza, R. D. L., & Asnis, G. M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02757-4 · Cited by 67
Multimodal Investigations of Reward Circuitry and Anhedonia in Adolescent Depression
Ely, B. A., Nguyen, T. N. B., Tobe, R. H., Walker, A., & Gabbay, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.678709 · Cited by 59
Schaefer, M., & Mauss, S. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801020177 · Cited by 53
Huckans, M. S., Fuller, B. E., Wheaton, V. R., Jaehnert, S., Ellis, C. C., Kolessar, M., Kříž, D., Anderson, J. R., Berggren, K., Olavarria, H., et al. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.07.020 · Cited by 53
Anhedonia as a clinical correlate of inflammation in adolescents across psychiatric conditions
Freed, R. D., Mehra, L. M., Laor, D., Patel, M., Alonso, C. M., Kim‐Schulze, S., & Gabbay, V. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1482000 · Cited by 46
Effect of Interferon-α on cognitive functioning in patients with chronic hepatitis C
HILSABECK, R. C., HASSANEIN, T. I., ZIEGLER, E. A., CARLSON, M. D., & PERRY, W. (2005) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617705050022 · Cited by 40
Hepatitis C Treatment for People With Severe Mental Illness
Mistler, L. A., Brunette, M. F., Marsh, B. J., Vidaver, R. M., Luckoor, R., & Rosenberg, S. D. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.2.93 · Cited by 39
Kim, K., Choi, Y., Lim, Y.-H., & Hong, Y. (2015) · Environmental Research · doi:10.1016/j.envres.2015.11.021 · Cited by 40
Fontana, R. J., Bieliauskas, L. A., Lindsay, K. L., Back‐Madruga, C., Wright, E. C., Snow, K. K., Lok, A. S. F., Kronfol, Z., & Padmanabhan, L. (2007) · Hepatology · doi:10.1002/hep.21633 · Cited by 38
Reder, A. T., & Feng, X. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00281 · Cited by 44
Neri, S., Bertino, G., Petralia, A., Giancarlo, C., Rizzotto, A., Calvagno, G. S., Mauceri, B., Abate, G., Boemi, P., Di Pino, A., et al. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181d88af5 · Cited by 37
Brick by Brick: Building a Transdiagnostic Understanding of Inflammation in Psychiatry
Thylur, D. S., & Goldsmith, D. R. (2022) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000326 · Cited by 44
Improvements in brain and behavior following eradication of hepatitis C
Kuhn, T. P., Sayegh, P., Jones, J. D., Smith, J., Sarma, M. K., Ragin, A. B., Singer, E. J., Thomas, M. A., Thames, A. D., Castellon, S. A., et al. (2017) · Journal of NeuroVirology · doi:10.1007/s13365-017-0533-0 · Cited by 37
Cassol, E., Misra, V., Morgello, S., Kirk, G. D., Mehta, S. H., & Gabuzda, D. H. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000551 · Cited by 41
An Overview of Psychiatric Issues in Liver Disease for the Consultation–Liaison Psychiatrist
Crone, C. C., Gabriel, G. M., & DiMartini, A. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.3.188 · Cited by 42
Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV
Weiss, J. J., & Gorman, J. M. (2006) · Current HIV/AIDS Reports · doi:10.1007/s11904-006-0013-2 · Cited by 31
Vesco, A. T., Young, A. S., Arnold, L. E., & Fristad, M. A. (2017) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12830 · Cited by 32
Hilsabeck, R. C., Anstead, G. M., Webb, A., Hoyumpa, A., Ingmundson, P. T., Holliday, S., Zhang, Q., Casas, Á., Jovel, M., & Stern, S. L. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.01.017 · Cited by 34
Neri, S., Pulvirenti, D., & Bertino, G. (2006) · Clinical Drug Investigation · doi:10.2165/00044011-200626110-00005 · Cited by 38
Optimizing the exercise prescription for depression: the search for biomarkers of response
Medina, J. L., Jacquart, J., & Smits, J. A. J. (2015) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2015.02.003 · Cited by 33
Karrenbauer, B. D., Müller, C. P., Ho, Y., Spanagel, R., Huston, J. P., Schwarting, R. K. W., & Pawlak, C. R. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.05.011 · Cited by 30
Goldsmith, D. R., Massa, N., Pearce, B. D., Wommack, E. C., Alrohaibani, A., Goel, N., Cuthbert, B. N., Fargotstein, M., Felger, J. C., Haroon, E., et al. (2020) · Schizophrenia · doi:10.1038/s41537-020-0098-4 · Cited by 31
Greene, R. K., Walsh, E. C., Mosner, M. G., & Dichter, G. S. (2018) · Biological Psychology · doi:10.1016/j.biopsycho.2018.12.008 · Cited by 30
Jung, M., Ryu, S., Kang, M., Javadi, A., & Loprinzi, P. D. (2021) · Quarterly Journal of Experimental Psychology · doi:10.1177/17470218211048807 · Cited by 32
Tagliapietra, M., & Monaco, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072478 · Cited by 26
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
Mancini, M., Natoli, S., Gardoni, F., Luca, M. D., & Pisani, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065618 · Cited by 28
Interferon-α-induced deficits in novel object recognition are rescued by chronic exercise
Fahey, B., Barlow, S. H., Day, J. S., & O’Mara, S. M. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.05.008 · Cited by 27
Pegylated-interferon-α2ain clinical practice: how to manage patients suffering from side effects
Calvaruso, V., Mazza, M., & Almasio, P. L. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.559161 · Cited by 28
Callaghan, C. K., Rouine, J., & O’Mara, S. M. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.07.018 · Cited by 26
Liu, Q., Ely, B. A., Simkovic, S. J., Tao, A., Wolchok, R. E., Alonso, C. M., & Gabbay, V. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100153 · Cited by 26
Trus, I., Udenze, D., Cox, B., Berube, N., Nordquist, R. E., van der Staay, F. J., Huang, Y., Kobinger, G., Safronetz, D., Gerdts, V., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1008038 · Cited by 23
Metadata
- Authors
- Juengling, F. D., Ebert, D., Gut, O., Engelbrecht, M. A., Rasenack, J., Nitzsche, E. U., Bauer, J., & Lieb, K.
- Affiliations
- University of Freiburg (DE)
- Venue
- Psychopharmacology
- Published
- 2000-11-17
- Volume
- 152
- Issue
- 4
- Pages
- 383-389
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2021594711
- Cited by
- 149
- References
- 0
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 6 · 2020: 3 · 2019: 5 · 2018: 6 · 2017: 9 · 2016: 6 · 2015: 9 · 2014: 5 · 2013: 7 · 2012: 5
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- interferon-alpha, low-dose interferon, brain glucose metabolism, depression, chronic hepatitis C, FDG-PET
- MeSH terms
- Adult, Antiviral Agents, Female, Glucose, Hepatitis C, Humans, Male, Middle Aged, Neuropsychological Tests, Prospective Studies, Tomography, Emission-Computed, Interferon-alpha, Prefrontal Cortex, Fluorodeoxyglucose F18
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.